PortfoliosLab logoPortfoliosLab logo
ISIN
US50540R4092
CUSIP
50540R409
IPO Date
Mar 29, 1990

Highlights

Market Cap
$21.09B
Enterprise Value
$28.04B
EPS (TTM)
$11.28
PE Ratio
22.56
Total Revenue (TTM)
$14.14B
Gross Profit (TTM)
$4.01B
EBITDA (TTM)
$1.90B
Year Range
$241.81 - $293.72
Target Price
$308.67
ROA (TTM)
4.93%
ROE (TTM)
10.79%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

LH Performance Chart

Laboratory Corporation of America Holdings (LH) is up 2.0% since the beginning of the year. At $254 per share, LH is trading 13.4% below its 52-week high of $294. Investors who bought $1,000 worth of LH shares 5 years ago would now be looking at an investment worth $1,181.


Loading charts...

S&P 500 Index

Returns By Period

Laboratory Corporation of America Holdings (LH) has returned 1.95% so far this year and -1.82% over the past 12 months. Over the last ten years, LH has returned 9.17% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Laboratory Corporation of America Holdings

1D
-0.54%
1M
-1.85%
YTD
1.95%
6M
0.28%
1Y
-1.82%
3Y*
9.35%
5Y*
3.39%
10Y*
9.17%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LH Monthly Returns History

Based on dividend-adjusted daily data since Mar 29, 1990, LH's average daily return is +0.06%, while the average monthly return is +1.04%. At this rate, an investment would double in approximately 5.6 years.

Historically, 57% of months were positive and 43% were negative. The best month was Sep 1998 with a return of +44.4%, while the worst month was Aug 1998 at -47.1%. The longest winning streak lasted 12 consecutive months, and the longest losing streak was 5 months.

On a daily basis, LH closed higher 48% of trading days. The best single day was Sep 1, 1998 with a return of +27.8%, while the worst single day was Aug 2, 1996 at -35.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20268.23%6.75%-7.72%-3.75%1.55%-2.16%1.95%
20258.93%0.78%-7.29%3.55%3.60%5.44%-0.93%7.16%3.26%-11.53%6.12%-6.66%10.62%
2024-2.20%-2.59%1.22%-7.82%-2.85%4.41%5.86%7.04%-2.79%2.14%5.96%-4.91%2.22%
20237.07%-4.78%-4.15%-1.18%-5.94%13.55%3.18%-2.40%-3.39%-0.66%8.98%4.79%13.82%
2022-13.64%-0.04%-2.80%-8.87%2.98%-5.01%11.87%-13.84%-9.08%8.32%8.81%-2.17%-24.41%
202112.46%4.81%6.30%4.25%3.24%0.50%7.36%2.44%-7.23%1.98%-0.59%10.12%54.37%

Benchmark Metrics

Laboratory Corporation of America Holdings has an annualized alpha of 7.21%, beta of 0.71, and R2 of 0.11 versus S&P 500 Index. Calculated based on daily prices since March 29, 1990.

  • This stock participated in 56.56% of S&P 500 Index downside but only 55.76% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.11 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
7.21%
Beta
0.71
0.11
Upside Capture
55.76%
Downside Capture
56.56%

Return for Risk

Risk / Return Rank

LH ranks 36 for risk / return — below 36% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


LH Risk / Return Rank: 3636
Overall Rank
LH Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
LH Sortino Ratio Rank: 3333
Sortino Ratio Rank
LH Omega Ratio Rank: 3232
Omega Ratio Rank
LH Calmar Ratio Rank: 3838
Calmar Ratio Rank
LH Martin Ratio Rank: 3838
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LHBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.11

Sortino ratioReturn per unit of downside risk

-2.70

Omega ratioGain probability vs. loss probability

1.01

1.37

-0.36

Calmar ratioReturn relative to maximum drawdown

-0.12

2.78

-2.90

Martin ratioReturn relative to average drawdown

-0.24

12.44

-12.68

Dividends

Dividend History

Laboratory Corporation of America Holdings provided a 1.13% dividend yield over the last twelve months, with an annual payout of $2.88 per share. The company has been increasing its dividends for 3 consecutive years.


0.90%1.00%1.10%1.20%1.30%$0.00$0.50$1.00$1.50$2.00$2.50$3.002022202320242025
Dividends
Dividend Yield
PeriodTTM2025202420232022
Dividend$2.88$2.88$2.88$2.68$1.86

Dividend yield

1.13%1.15%1.26%1.18%0.92%

Monthly Dividends

The table displays the monthly dividend distributions for Laboratory Corporation of America Holdings. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.72$0.00$0.00$0.72$0.00$1.44
2025$0.00$0.72$0.00$0.00$0.72$0.00$0.00$0.72$0.00$0.00$0.72$0.00$2.88
2024$0.00$0.72$0.00$0.00$0.72$0.00$0.00$0.72$0.00$0.00$0.72$0.00$2.88
2023$0.00$0.62$0.00$0.00$0.62$0.00$0.00$0.72$0.00$0.00$0.72$0.00$2.68
2022$0.62$0.00$0.00$0.62$0.00$0.00$0.62$0.00$1.86

Dividend Yield & Payout


Dividend Yield

Laboratory Corporation of America Holdings has a dividend yield of 1.13%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

Laboratory Corporation of America Holdings has a payout ratio of 25.52%, which is quite average when compared to the overall market. This suggests that Laboratory Corporation of America Holdings strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Laboratory Corporation of America Holdings. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Laboratory Corporation of America Holdings was 96.15%, occurring on Aug 31, 1998. Recovery took 2089 trading sessions.

The current Laboratory Corporation of America Holdings drawdown is 11.85%.


Related event

Drawdown

Fall

Recovery

Underwater

1998 bear market1998
-96.15%Aug 1998
6y 8mo8y 3mo
14y 11moDec 1991 - Dec 2006
COVID crash2020
-46.58%Mar 2020
1mo 4d3mo 29d
5mo 3dFeb 2020 - Jul 2020
1991 bear market1991
-44.70%Jan 1991
5mo 18d2mo 17d
8mo 5dJul 1990 - Mar 1991
Rate-hike selloffLate 2018
-36.21%Dec 2018
6mo 9d1y 1mo
1y 8moJun 2018 - Feb 2020
Bear market2022
-34.61%Oct 2022
9mo 11d2y 8mo
3y 5moJan 2022 - Jun 2025

Drawdown Indicators


LHBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-96.15%

-56.78%

-39.37%

Max Drawdown (1Y)

Largest decline over 1 year

-15.22%

-9.10%

-6.12%

Max Drawdown (3Y)

Largest decline over 3 years

-17.36%

-18.90%

+1.54%

Max Drawdown (5Y)

Largest decline over 5 years

-34.61%

-25.43%

-9.18%

Max Drawdown (10Y)

Largest decline over 10 years

-46.58%

-33.92%

-12.66%

Current Drawdown

Current decline from peak

-11.85%

-1.80%

-10.05%

Average Drawdown

Average peak-to-trough decline

-29.59%

-10.71%

-18.88%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.62%

2.03%

+5.59%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Laboratory Corporation of America Holdings over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Laboratory Corporation of America Holdings is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for LH, comparing it with other companies in the Diagnostics & Research industry. Currently, LH has a P/E ratio of 22.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for LH relative to other companies in the Diagnostics & Research industry. Currently, LH has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for LH in comparison with other companies in the Diagnostics & Research industry. Currently, LH has a P/B value of 2.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with LH

Add Laboratory Corporation of America Holdings to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with LH